Balance Sheet
Accounts PayablesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Vanda Pharmaceuticals (VNDA) Current Assets: 2010-2024

Historic Current Assets for Vanda Pharmaceuticals (VNDA) over the last 15 years, with Dec 2024 value amounting to $438.9 million.

  • Vanda Pharmaceuticals' Current Assets fell 15.01% to $367.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $367.5 million, marking a year-over-year decrease of 15.01%. This contributed to the annual value of $438.9 million for FY2024, which is 1.37% up from last year.
  • According to the latest figures from FY2024, Vanda Pharmaceuticals' Current Assets is $438.9 million, which was up 1.37% from $432.9 million recorded in FY2023.
  • In the past 5 years, Vanda Pharmaceuticals' Current Assets ranged from a high of $519.3 million in FY2022 and a low of $409.1 million during FY2020.
  • Over the past 3 years, Vanda Pharmaceuticals' median Current Assets value was $438.9 million (recorded in 2024), while the average stood at $463.7 million.
  • Its Current Assets has fluctuated over the past 5 years, first rose by 16.90% in 2021, then dropped by 16.63% in 2023.
  • Over the past 5 years, Vanda Pharmaceuticals' Current Assets (Yearly) stood at $409.1 million in 2020, then climbed by 16.90% to $478.3 million in 2021, then increased by 8.57% to $519.3 million in 2022, then dropped by 16.63% to $432.9 million in 2023, then increased by 1.37% to $438.9 million in 2024.